FDA approves Supernus’ Parkinson’s drug-device after two rejections

At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo. Onapgo is now approved to treat motor fluctuations in adults with advanced Parkinson’s disease ...